Page 14 - Demo
P. 14

Cancer Care |
Next-gen cancer therapy without the next-gen price tag
  Christiana Care is first in Delaware to integrate MRI-based planning with HDR brachytherapy for gynecological cancers. Innovative adaptation of existing technology enabled this next-generation therapy without the need to invest in a costly new MRI scanner.
Everything went according to plan in January when ex- perts at Christiana Care's Helen F. Graham Cancer Center & Research Institute treated their first cervical cancer patient with integrated magnetic resonance imaging
(MRI)-based planning for high-dose-rate (HDR) brachytherapy. The event marked a significant technological step forward in cancer treatment for patients in Delaware, and it also exemplified Christiana Care's focus on using resources wisely and effectively.
“With the help of our colleagues in Radiology and Anesthesia, we were able to adapt existing resources and avoid the high costs of purchasing a dedicated MRI scanner — a potential investment of more than $4 million,” said Chief Clinical Physicist Firas Mourtada, MSE, Ph.D., D.ABR. “Together, we have succeeded in achieving better value and an improved treatment experience for

   12   13   14   15   16